Anthera Pharmaceuticals‚ Inc.

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to address significant unmet medical needs. While the company's website (http://www.anthera.com/) is currently offline, information gleaned from past online presence and news articles indicates their primary area of focus was on the development of therapies for autoimmune and inflammatory diseases.

Historically, Anthera's pipeline included several drug candidates targeting these therapeutic areas. These candidates were likely at various stages of development, ranging from preclinical research to clinical trials. The company aimed to develop innovative treatment options with improved efficacy and safety profiles compared to existing therapies. Specific details about the exact nature of the drug candidates and their development stages are not readily available due to the unavailability of the company website.